Clinical Trials in San Antonio

Showing 5241-5260 of 14,633 trials

Hepatic Impairment Study for Lorlatinib in Cancer Patients

NCT03726333

This is a phase 1 study in advanced cancer patients with varied hepatic functions to evaluate the potential effect of hepatic impairment on pharmacokinetics and safety of lorlatinib and provide dose recommendation for patients with hepatic impairment if possible.

Advanced Cancers

Pfizer1 participantsStarted Jan 2020

Aurora, Colorado, United States • Aurora, Colorado, United States • Aurora, Colorado, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690

The primary objectives of this study were to evaluate the safety and efficacy of LKA651 in patients with macular edema from diabetic macular edema (DME),

Diabetic Macular Edema

Novartis Pharmaceuticals91 participantsStarted May 2019

Beverly Hills, California, United States • Rancho Cordova, California, United States • Miami, Florida, United States +19 more locations

Hepatic Impairment Study for Lorlatinib in Cancer Patients

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Find Trials by Condition in San Antonio

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Open-Label Study of Oral Treprostinil in Digital Ulcers

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria